Yongzheng Zhang

Xinjiang Medical University — China

Biochemistry, Genetics and Molecular Biology · Life Sciences

9h-index395citations23works2.82yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Antibiotic Resistance in Bacteria(5), Antibiotics Pharmacokinetics and Efficacy(3), Antimicrobial Peptides and Activities(3), Bacterial Genetics and Biotechnology(2), Antimicrobial Resistance in Staphylococcus(2)

Publications22 total

Dual inhibition of EGR1/STAT3 transcriptional hubs suppresses macrophage-driven liver fibrosis: A multi-omics-guided drug repurposing strategy
Biochemical Pharmacology·2025· 1 cited
TXA11114: Discovery of an <i>in vivo</i> efficacious efflux pump inhibitor in <i>Pseudomonas aeruginosa</i>
2025· 1 citedOpen Access
Identification of macrophage driver genes in fibrosis caused by different heart diseases based on omics integration
Journal of Translational Medicine·2024· 9 citedOpen Access
The Role of Ferroptosis Driver Genes in Glioma Progression and Potential Treatment Options
SSRN Electronic Journal·2024Open Access
Corrigendum: Exploring the molecular mechanism of hepatitis virus inducing hepatocellular carcinoma by microarray data and immune infiltrates analysis
Frontiers in Immunology·2023Open Access
Exploring the molecular mechanism of hepatitis virus inducing hepatocellular carcinoma by microarray data and immune infiltrates analysis
Frontiers in Immunology·2022· 13 citedOpen Access
Bergamottin and PAP-1 Induced ACE2 Degradation to Alleviate Infection of SARS-CoV-2
International Journal of Molecular Sciences·2022· 6 citedOpen Access
The In Vitro Effect of Psoralen on Glioma Based on Network Pharmacology and Potential Target Research
Evidence-based Complementary and Alternative Medicine·2022· 8 citedOpen Access
Evaluation of A22 Analogs as Gram-negative Antimicrobial Agents
Research Square (Research Square)·2022Open Access
Evaluation of a Conformationally Constrained Indole Carboxamide as a Potential Efflux Pump Inhibitor in Pseudomonas aeruginosa
Antibiotics·2022· 19 citedOpen Access
Etiology and Chinese Medicine Screening of Severe COVID-19 Based on Multiomics and Serum Pharmacology
2022· 1 citedOpen Access
Evaluation of Heterocyclic Carboxamides as Potential Efflux Pump Inhibitors in Pseudomonas aeruginosa
Antibiotics·2021· 14 citedOpen Access
Catalpol alleviates ovalbumin-induced asthma in mice: Reduced eosinophil infiltration in the lung
International Immunopharmacology·2016· 40 cited
Construction of Recombinant Pichia pastoris Carrying a Constitutive AvBD9 Gene and Analysis of Its Activity
Journal of Microbiology and Biotechnology·2015· 8 cited
Inhibition of RND-type efflux pumps confers the FtsZ-directed prodrug TXY436 with activity against Gram-negative bacteria
Biochemical Pharmacology·2014· 35 cited
[Role of water-water circulation in excessive light energy dissipation of ginger leaves].
PubMed·2014
[Effects of water and light interaction on reactive oxygen metabolism in ginger leaves].
PubMed·2013· 3 cited
Pharmacokinetics and in vivo antistaphylococcal efficacy of TXY541, a 1-methylpiperidine-4-carboxamide prodrug of PC190723
Biochemical Pharmacology·2013· 46 cited
Enterococcal and streptococcal resistance to PC190723 and related compounds: Molecular insights from a FtsZ mutational analysis
Biochimie·2013· 26 citedOpen Access
Discovery of Brivanib Alaninate ((<i>S</i>)-((<i>R</i>)-1-(4-(4-Fluoro-2-methyl-1<i>H</i>-indol-5-yloxy)-5-methylpyrrolo[2,1-<i>f</i>][1,2,4]triazin-6-yloxy)propan-2-yl)2-aminopropanoate), A Novel Prodrug of Dual Vascular Endothelial Growth Factor Receptor-2 and Fibroblast Growth Factor Receptor-1 Kinase Inhibitor (BMS-540215)
Journal of Medicinal Chemistry·2008· 141 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Lufeng Cheng(6), Ajit K. Parhi(5), Pratik Datta(4), Yang Wu(4), Malvika Kaul(3), Edmond J. LaVoie(3), Daniel S. Pilch(3), Jesús D. Rosado-Lugo(3), Yi Yuan(3), Amir Zeb(3), Mengjia Li(3), Meng‐Jia Li(3), Yangsheng Sun(2), Yanlu Cao(2), Anamika Banerjee(2), Lu-Feng Cheng(2), Haidong Li(2), Xiu Li(2), Ajit K Parhi(2), Zhen‐Wei Cai(1)